Profil
Gregory D.
Kunst is currently Chief Executive Officer & Director at Valitor, Inc. since 2025 and Director at Pr3vent, Inc. Former positions include Co-Chief Executive Officer & Director at Aurion Biotech, Inc., Global Marketing Director at Alcon, Inc., and Vice President-Global Marketing at Glaukos Corp.
Education includes an MBA from Vanderbilt University and an undergraduate degree from Brigham Young University.
Postes actifs de Gregory Kunst
| Sociétés | Poste | Début |
|---|---|---|
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Directeur/Membre du Conseil | - |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Directeur Général | 17/10/2025 |
Anciens postes connus de Gregory Kunst
| Sociétés | Poste | Fin |
|---|---|---|
| GLAUKOS CORPORATION | Sales & Marketing | - |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Directeur Général | - |
Formation de Gregory Kunst
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Glaukos Corp.
Glaukos Corp. Medical SpecialtiesHealth Technology Operates as an ophthalmic medical device company | Health Technology |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Valitor, Inc.
Valitor, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel methods of modifying therapeutic proteins | Health Technology |
Pr3vent, Inc
Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Health Services |
Aurion Biotech, Inc.
Aurion Biotech, Inc. BiotechnologyHealth Technology Develops advanced cell therapies to treat eye diseases | Health Technology |
















